Rabadrop, Oral suspension
Rabadrop, Oral suspension
Authorised
- Rabies virus, strain SAD, Live
Product identification
Medicine name:
Rabadrop, Oral suspension
Rabadrop, Perorální suspenze
Active substance:
- Rabies virus, strain SAD, Live
Target species:
-
Fox
-
Raccoon dog
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Rabies virus, strain SAD, Live8.50/log10 tissue culture infective dose 501.00Dose
Pharmaceutical form:
-
Oral suspension
Withdrawal period by route of administration:
-
Oral use
- Fox
- Raccoon dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07BD
Legal status of supply:
This information is not available for this product.
Authorisation status:
-
Valid
Authorised in:
-
Czechia
Package description:
- Plastic Sachet 2 x 350.0 Dose
- Plastic Sachet 1 x 700.0 Dose
- Plastic Sachet 1 x 30.0 Dose
- Paper Box 30 x 20.0 Dose
- Paper Box 1 x 20.0 Dose
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Institute For State Control Of Veterinary Biologicals And Medicines
Authorisation number:
- 97/047/19-C
Date of authorisation status change:
Reference member state:
-
Czechia
Procedure number:
- CZ/V/0149/001
Concerned member states:
-
Bulgaria
-
Croatia
-
Estonia
-
Finland
-
Germany
-
Greece
-
Hungary
-
Latvia
-
Lithuania
-
Poland
-
Romania
-
Slovakia
-
Slovenia
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 24/05/2022
Czech (PDF)
Published on: 24/05/2022
eu-puar-czv0149001-mr-rabadrop-en.pdf
English (PDF)
Download Published on: 16/11/2023
How useful was this page?:
